Good morning. I'm James Holman from the Washington Post and this is the Daily

2002 for Tuesday, May 12. In today's news, the White House implements a stringent mask policy, but President Trump

still won't wear one.

Thermal scanners are the latest technology being used to detect the contagion, they don't really work. And after years

of struggles amid Trump's trade wars, farmers and ranchers face their worst crisis since

the early 1980s.

But first, the big idea.

Johnson and Johnson's race to manufacture a billion doses of coronavirus vaccine is ramping up in a small

biotechnology plant near Interstate 95 in Baltimore. But even as technicians

prepare to brew the first batches of an experimental vaccine,

international concern is bubbling about what countries will get the first inoculations.

The Baltimore plant is the second of four

locations around the world where J&J plans to pump out vaccine on a massive scale,

months before testing the first dose in a human being.

The manufacturing head start is one part of a worldwide scramble

to protect the human race from the virus,

which is not expected to vanish on its own.

If this novel coronavirus establishes itself as a stubborn endemic virus like influenza,

medical experts say there almost certainly will not be enough vaccine

for at least several years,

even with the unprecedented effort to manufacture billions of doses.

Scientists say that about 70% of the world's population or 5.6 billion people

...